218 related articles for article (PubMed ID: 11285571)
1. Differential IgM response to conformational and linear epitopes of parvovirus B19 VP1 and VP2 structural proteins.
Manaresi E; Zuffi E; Gallinella G; Gentilomi G; Zerbini M; Musiani M
J Med Virol; 2001 May; 64(1):67-73. PubMed ID: 11285571
[TBL] [Abstract][Full Text] [Related]
2. Antibody response to B19 parvovirus VP1 and VP2 linear epitopes in patients with haemophilic arthritis.
Azzi A; Manaresi E; Zakrzewska K; DeSantis R; Musiani M; Zerbini M
J Med Virol; 2004 Apr; 72(4):679-82. PubMed ID: 14981773
[TBL] [Abstract][Full Text] [Related]
3. Undenatured parvovirus B19 antigens are essential for the accurate detection of parvovirus B19 IgG.
Kerr S; O'Keeffe G; Kilty C; Doyle S
J Med Virol; 1999 Feb; 57(2):179-85. PubMed ID: 9892405
[TBL] [Abstract][Full Text] [Related]
4. IgG immune response to B19 parvovirus VP1 and VP2 linear epitopes by immunoblot assay.
Manaresi E; Gallinella G; Zerbini M; Venturoli S; Gentilomi G; Musiani M
J Med Virol; 1999 Feb; 57(2):174-8. PubMed ID: 9892404
[TBL] [Abstract][Full Text] [Related]
5. Detection of parvovirus B19 IgG: choice of antigens and serological tests.
Manaresi E; Gallinella G; Venturoli S; Zerbini M; Musiani M
J Clin Virol; 2004 Jan; 29(1):51-3. PubMed ID: 14675870
[TBL] [Abstract][Full Text] [Related]
6. Parvovirus B19 viral loads in relation to VP1 and VP2 antibody responses in diagnostic blood samples.
Beersma MF; Claas EC; Sopaheluakan T; Kroes AC
J Clin Virol; 2005 Sep; 34(1):71-5. PubMed ID: 15985386
[TBL] [Abstract][Full Text] [Related]
7. B cell memory is directed toward conformational epitopes of parvovirus B19 capsid proteins and the unique region of VP1.
Corcoran A; Mahon BP; Doyle S
J Infect Dis; 2004 May; 189(10):1873-80. PubMed ID: 15122524
[TBL] [Abstract][Full Text] [Related]
8. Seroprevalence of IgG against conformational and linear capsid antigens of parvovirus B19 in Italian blood donors.
Manaresi E; Gallinella G; Morselli Labate AM; Zucchelli P; Zaccarelli D; Ambretti S; Delbarba S; Zerbini M; Musiani M
Epidemiol Infect; 2004 Oct; 132(5):857-62. PubMed ID: 15473148
[TBL] [Abstract][Full Text] [Related]
9. Epitope type-specific IgG responses to capsid proteins VP1 and VP2 of human parvovirus B19.
Söderlund M; Brown CS; Spaan WJ; Hedman L; Hedman K
J Infect Dis; 1995 Dec; 172(6):1431-6. PubMed ID: 7594699
[TBL] [Abstract][Full Text] [Related]
10. Anti-VP1 and anti-VP2 antibodies detected by immunofluorescence assays in patients with acute human parvovirus B19 infection.
Pereira RF; Paula WN; Cubel Rde C; Nascimento JP
Mem Inst Oswaldo Cruz; 2001 May; 96(4):507-13. PubMed ID: 11391423
[TBL] [Abstract][Full Text] [Related]
11. Detection of parvovirus B19 NS1-specific antibodies by ELISA and western blotting employing recombinant NS1 protein as antigen.
Heegaard ED; Rasksen CJ; Christensen J
J Med Virol; 2002 Jul; 67(3):375-83. PubMed ID: 12116031
[TBL] [Abstract][Full Text] [Related]
12. Immunoglobulin M and G immunoblots in the diagnosis of parvovirus B19 infection.
Chen MY; Lee KL; Hung CC
J Formos Med Assoc; 2000 Jan; 99(1):24-32. PubMed ID: 10743343
[TBL] [Abstract][Full Text] [Related]
13. Chemiluminescence Western blot assay for the detection of immunity against parvovirus B19 VP1 and VP2 linear epitopes using a videocamera based luminograph.
Manaresi E; Pasini P; Gallinella G; Gentilomi G; Venturoli S; Roda A; Zerbini M; Musiani M
J Virol Methods; 1999 Aug; 81(1-2):91-9. PubMed ID: 10488766
[TBL] [Abstract][Full Text] [Related]
14. Comparison of a baculovirus-based VP2 enzyme immunoassay (EIA) to an Escherichia coli-based VP1 EIA for detection of human parvovirus B19 immunoglobulin M and immunoglobulin G in sera of pregnant women.
Jordan JA
J Clin Microbiol; 2000 Apr; 38(4):1472-5. PubMed ID: 10747128
[TBL] [Abstract][Full Text] [Related]
15. A synthetic parvovirus B19 capsid protein can replace viral antigen in antibody-capture enzyme immunoassays.
Kock WC
J Virol Methods; 1995 Sep; 55(1):67-82. PubMed ID: 8576310
[TBL] [Abstract][Full Text] [Related]
16. Baculovirus expression of parvovirus B19 (B19V) NS1: utility in confirming recent infection.
Ennis O; Corcoran A; Kavanagh K; Mahon BP; Doyle S
J Clin Virol; 2001 Aug; 22(1):55-60. PubMed ID: 11418353
[TBL] [Abstract][Full Text] [Related]
17. Immunoreactivity against linear epitopes of parvovirus B19 structural proteins. Immunodominance of the amino-terminal half of the unique region of VP1.
Musiani M; Manaresi E; Gallinella G; Venturoli S; Zuffi E; Zerbini M
J Med Virol; 2000 Mar; 60(3):347-52. PubMed ID: 10630969
[TBL] [Abstract][Full Text] [Related]
18. Diagnosis of human parvovirus B19 infections by detection of epitope-type-specific VP2 IgG.
Kaikkonen L; Söderlund-Venermo M; Brunstein J; Schou O; Panum Jensen I; Rousseau S; Caul EO; Cohen B; Valle M; Hedman L; Hedman K
J Med Virol; 2001 Jul; 64(3):360-5. PubMed ID: 11424127
[TBL] [Abstract][Full Text] [Related]
19. Human parvovirus B19: ELISA and immunoblot assays.
Schwarz TF; Roggendorf M; Deinhardt F
J Virol Methods; 1988 Jun; 20(2):155-68. PubMed ID: 2843558
[TBL] [Abstract][Full Text] [Related]
20. Long term follow up of serostatus after maternofetal parvovirus B19 infection.
Dembinski J; Eis-Hübinger AM; Maar J; Schild R; Bartmann P
Arch Dis Child; 2003 Mar; 88(3):219-21. PubMed ID: 12598382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
